Physician profile
Albert C Chen
NPI 1528079076
$994.42
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $118 · 2021: $305 · 2022: $249.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $269.00 | 2019-2022 | |
| Coloplast Corp | $166.16 | 2019-2021 | |
| Covidien Lp | $152.05 | 2019 | |
| Conmed Corporation | $138.31 | 2022 | |
| Mayne Pharma Commercial LLC | $45.75 | 2021-2022 | |
| Exeltis, USA INC. | $43.00 | 2020-2021 | |
| Intuitive Surgical, INC. | $33.67 | 2022 | |
| Ethicon US, LLC | $31.43 | 2019 | |
| Avion Pharmaceuticals | $25.17 | 2021 | |
| Dysis Medical, INC. | $24.56 | 2022 | |
| Roche Diagnostics Corporation | $18.92 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.36 | 2019 | |
| Medicem INC. | $16.03 | 2021 | |
| Hologic Sales and Service, LLC | $14.01 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.